• Inden for 60 dage efter en vigtig milepæl er nået (lægemiddelovervågning eller risikominimering) m
• When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being ici